跳至主要内容
临床试验/NCT00238056
NCT00238056已完成2 期

Effect of Domperidone on QT Interval in Premature Infants

Nantes University Hospital2 个研究点 分布在 1 个国家开始时间: 2005年10月13日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
试验地点
2

研究概览

简要总结

30 premature infants treated by domperidone upon decision of the attending neonatologist will have a daily recording of electrocardiogram for the first 7 seven days of treatment, and pharmacokinetics dosages at Day 7. Their ECG will be compared to 30 non treated premature infants, matched for gestational age, postnatal age and sex.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Days 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Gestational age less than 36 weeksPostnatal age greater than 10 days Treated / not treated by domperidone (case/control)Signed parental informed consent

排除标准

  • Severe cardiac arrhythmia Congenital heart disease (persistent ductus arteriosus excluded)Familial history of congenital long QT syndrome

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验